Onconetix, Inc. Other Selling, General and Administrative Expense
Onconetix, Inc. (ONCO) reported Other Selling, General and Administrative Expense of $900.00 thousand for the 12-month period ending 2024-12-31, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2025-11-13
- Onconetix, Inc. other selling, general and administrative expense for the quarter ending 2024-12-31 was $500.00K.
- Onconetix, Inc. other selling, general and administrative expense for the quarter ending 2024-03-31 was $31.00K.
- Onconetix, Inc. other selling, general and administrative expense for fiscal 2022 was $1.30M.
| Period end | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 9 month | Other Selling, General and Administrative Expense 12 month | Other Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | $500.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-13 | $900.00K 10-Q · filed 2025-11-13 | ||
| 2024-09-30 | $400.00K 10-Q · filed 2024-12-10 | |||
| 2024-03-31 | $31.00K 10-Q · filed 2024-05-20 | |||
| 2023-12-31 | $1.40M 10-Q · filed 2025-11-13 | $6.00K 10-K · filed 2024-04-11 | ||
| 2022-12-31 | $1.30M 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |